DSM's Third Quarter Sales and Earnings Slide; Optimistic for Rest of the Year
08:28 AM | November 3, 2009 | Natasha Alperowicz
DSM's continuing operations showed a 29% drop to €257 million ($379.2 million) in profit before interest, tax, depreciation and amortization (Ebitda) in the third quarter of this year on sales 14%...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.